Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 790
Filtrer
1.
Elife ; 132024 Jul 17.
Article de Anglais | MEDLINE | ID: mdl-39017665

RÉSUMÉ

The lateral parafacial area (pFL) is a crucial region involved in respiratory control, particularly in generating active expiration through an expiratory oscillatory network. Active expiration involves rhythmic abdominal (ABD) muscle contractions during late-expiration, increasing ventilation during elevated respiratory demands. The precise anatomical location of the expiratory oscillator within the ventral medulla's rostro-caudal axis is debated. While some studies point to the caudal tip of the facial nucleus (VIIc) as the oscillator's core, others suggest more rostral areas. Our study employed bicuculline (a γ-aminobutyric acid type A [GABA-A] receptor antagonist) injections at various pFL sites (-0.2 mm to +0.8 mm from VIIc) to investigate the impact of GABAergic disinhibition on respiration. These injections consistently elicited ABD recruitment, but the response strength varied along the rostro-caudal zone. Remarkably, the most robust and enduring changes in tidal volume, minute ventilation, and combined respiratory responses occurred at more rostral pFL locations (+0.6/+0.8 mm from VIIc). Multivariate analysis of the respiratory cycle further differentiated between locations, revealing the core site for active expiration generation with this experimental approach. Our study advances our understanding of neural mechanisms governing active expiration and emphasizes the significance of investigating the rostral pFL region.


Sujet(s)
Bicuculline , Expiration , Bicuculline/pharmacologie , Bicuculline/administration et posologie , Animaux , Expiration/physiologie , Mâle , Respiration/effets des médicaments et des substances chimiques , Moelle allongée/physiologie , Moelle allongée/effets des médicaments et des substances chimiques , Antagonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/administration et posologie
2.
J Neurophysiol ; 132(1): 177-183, 2024 07 01.
Article de Anglais | MEDLINE | ID: mdl-38836296

RÉSUMÉ

The reliable induction of long-term potentiation (LTP) in the dentate gyrus (DG) in vitro requires the blockade of the γ-aminobutyric acid A (GABAA) receptor. In these studies we examined the effectiveness of the specific GABAA receptor antagonist bicuculline methiodide (BMI) in facilitating LTP in the DG from hippocampal slices obtained from either C57Bl/6 mice or Sprague-Dawley rats, two species commonly used for electrophysiology. In the C57Bl/6 mice, maximal short-term potentiation and LTP in the DG were produced with a concentration of 5 µM BMI. In contrast, a concentration of 10 µM BMI was required to produce maximal short-term potentiation and LTP in the DG of Sprague-Dawley rats. These results reveal that there are species differences in the optimal amount of BMI required to produce robust and reliable LTP in the rodent DG in vitro and highlight the need to take consideration of the species being used when choosing concentrations of pharmacological agents to employ for electrophysiological use.NEW & NOTEWORTHY In this report we provide specific neurophysiological evidence for concentrations of GABAA antagonist required to study long-term potentiation in the medial perforant pathway of the dentate gyrus. Two commonly used species, Sprague-Dawley rats and C57Bl/6 mice, require different concentrations of bicuculline methiodide to induce optimal short-term and long-term potentiation.


Sujet(s)
Bicuculline , Gyrus denté , Antagonistes du récepteur GABA-A , Potentialisation à long terme , Souris de lignée C57BL , Rat Sprague-Dawley , Animaux , Potentialisation à long terme/effets des médicaments et des substances chimiques , Potentialisation à long terme/physiologie , Gyrus denté/effets des médicaments et des substances chimiques , Gyrus denté/physiologie , Bicuculline/pharmacologie , Bicuculline/analogues et dérivés , Antagonistes du récepteur GABA-A/pharmacologie , Souris , Rats , Mâle , Récepteurs GABA-A/effets des médicaments et des substances chimiques , Récepteurs GABA-A/métabolisme , Récepteurs GABA-A/physiologie , Spécificité d'espèce
3.
Neurosci Biobehav Rev ; 161: 105668, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38608826

RÉSUMÉ

Neuroinflammation accompanies several brain disorders, either as a secondary consequence or as a primary cause and may contribute importantly to disease pathogenesis. Neurosteroids which act as Positive Steroid Allosteric GABA-A receptor Modulators (Steroid-PAM) appear to modulate neuroinflammation and their levels in the brain may vary because of increased or decreased local production or import from the systemic circulation. The increased synthesis of steroid-PAMs is possibly due to increased expression of the mitochondrial cholesterol transporting protein (TSPO) in neuroinflammatory tissue, and reduced production may be due to changes in the enzymatic activity. Microglia and astrocytes play an important role in neuroinflammation, and their production of inflammatory mediators can be both activated and inhibited by steroid-PAMs and GABA. What is surprising is the finding that both allopregnanolone, a steroid-PAM, and golexanolone, a novel GABA-A receptor modulating steroid antagonist (GAMSA), can inhibit microglia and astrocyte activation and normalize their function. This review focuses on the role of steroid-PAMs in neuroinflammation and their importance in new therapeutic approaches to CNS and liver disease.


Sujet(s)
Maladies neuro-inflammatoires , Prégnanolone , Prégnanolone/pharmacologie , Prégnanolone/métabolisme , Humains , Animaux , Maladies neuro-inflammatoires/traitement médicamenteux , Maladies neuro-inflammatoires/métabolisme , Microglie/effets des médicaments et des substances chimiques , Microglie/métabolisme , Astrocytes/effets des médicaments et des substances chimiques , Astrocytes/métabolisme , Antagonistes du récepteur GABA-A/pharmacologie
4.
Brain Res Bull ; 192: 128-141, 2023 Jan.
Article de Anglais | MEDLINE | ID: mdl-36414159

RÉSUMÉ

RATIONALE: Several lines of evidence have demonstrated that the cannabinoid type 1 receptor (CB1) is found in the caudate nucleus and putamen (CPu) in addition to the substantia nigra pars reticulata (SNpr). Here, we investigated the role of endocannabinoid neuromodulation of striato-nigral disinhibitory projections on the activity of nigro-collicular GABAergic pathways that control the expression of unconditioned fear-related behavioural responses elicited by microinjections of the GABAA receptor selective antagonist bicuculline (BIC) in the deep layers of the superior colliculus (dlSC). METHODS: Fluorescent neural tract tracers were deposited in either CPu or in SNpr. Wistar rats received injection of vehicle, anandamide (AEA), either at low (50 pmol) or high (100 pmol) concentrations in CPu followed by bicuculline microinjections in dlSC. RESULTS: Connections between CPu, the SNpr and dlSC were demonstrated. The GABAA receptor blockade in dlSC elicited panic-like behaviour. AEA at the lowest concentration caused a panicolytic-like effect that was antagonised by the CPu pretreatment with AM251 at 100 pmol. AEA at the highest concentration caused a panicogenic-like effect that was antagonised by the CPu pretreatment with 6-iodonordihydrocapsaicin (6-I-CPS) at different concentrations (0.6, 6, 60 nmol). CONCLUSION: These findings suggest that while pre-synaptic CB1-signalling subserves an indirect facilitatory effect of AEA on striato-nigral pathways causing panicolytic-like responses through midbrain tectum enhanced activity, post-synaptic TRPV1-signalling in CPu mediates AEA direct activation of striato-nigral disinhibitory pathways resulting in increasing dlSC neurons activity and a panicogenic-like response. All these actions seem to depend on the interface with the nigro-collicular inhibitory GABAergic pathways.


Sujet(s)
Récepteurs GABA-A , Substantia nigra , Animaux , Rats , Récepteurs GABA-A/métabolisme , Rat Wistar , Bicuculline/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Voies nerveuses/physiologie
5.
Brain Res ; 1797: 148128, 2022 12 15.
Article de Anglais | MEDLINE | ID: mdl-36265669

RÉSUMÉ

Here we studied spinal neurotransmitter mechanisms involved in the reduction of mechanical hypersensitivity by inhibition of the amygdaloid central nucleus (CeA) in male and female rats with spared nerve injury (SNI) model of neuropathy. SNI induced mechanical hypersensitivity that was stronger in females. Reversible blocking of the CeA with muscimol (GABAA receptor agonist) induced a reduction of mechanical hypersensitivity that did not differ between males and females. Following spinal co-administration of atipamezole (α2-adrenoceptor antagonist), the reduction of mechanical hypersensitivity by CeA muscimol was attenuated more in males than females. In contrast, following spinal co-administration of raclopride (dopamine D2 receptor antagonist) the reduction of hypersensitivity by CeA muscimol was attenuated more in females than males. The reduction of mechanical hypersensitivity by CeA muscimol was equally attenuated in males and females by spinal co-administration of WAY-100635 (5-HT1A receptor antagonist) or bicuculline (GABAA receptor antagonist). The CeA muscimol induced attenuation of ongoing pain-like behavior (conditioned place preference test) that was reversed by spinal co-administration of atipamezole in both sexes. The results support the hypothesis that CeA contributes to mechanical hypersensitivity and ongoing pain-like behavior in SNI males and females. Disinhibition of descending controls acting on spinal α2-adrenoceptors, 5-HT1A, dopamine D2 and GABAA receptors provides a plausible explanation for the reduction of mechanical hypersensitivity by CeA block in SNI. The involvement of spinal dopamine D2 receptors and α2-adrenoceptors in the CeA muscimol-induced reduction of mechanical hypersensitivity is sexually dimorphic, unlike that of spinal α2-adrenoceptors in the reduction of ongoing neuropathic pain.


Sujet(s)
Névralgie , Récepteurs GABA-A , Femelle , Rats , Mâle , Animaux , Muscimol/pharmacologie , Névralgie/traitement médicamenteux , Amygdale (système limbique) , Récepteurs aux neuromédiateurs , Antagonistes du récepteur GABA-A/pharmacologie , Récepteurs adrénergiques
6.
J Steroid Biochem Mol Biol ; 224: 106158, 2022 11.
Article de Anglais | MEDLINE | ID: mdl-35931327

RÉSUMÉ

γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter. GABA receptor type A (GABAAR) possesses binding sites for a large group of pharmacological agents which are supposed to interact allosterically with each other. The aim of this work was to study the interaction between the positive allosteric modulators (PAMs) and the competitive antagonists of GABAARs. The GABA-induced chloride current (IGABA) was measured in isolated Purkinje cells of rat cerebellum using the patch-clamp technique. PAMs, neurosteroid allopregnanolone (Allo) and zolpidem (Zolp), a drug that positively modulates the GABAAR through interaction with the benzodiazepine (BDZ) site, doubled the IGABA amplitude in the control solution. Competitive antagonist of GABAARs, bicuculline (Bic, 5 µM) blocked the IGABA by 90%. The addition of 1 µM Allo or 0.5 µM Zolp to the Bic solution caused an unblocking effect, so that the IGABA amplitude increased 10 and 4 times from control value, correspondingly. This unblocking effect developed slowly, as evidenced by a threefold increase in the current rise time. Competitive antagonist of GABAARs, gabazine (GBZ, 0.5 µM) blocked the IGABA by 87%. The addition of 1 µM Allo to the GBZ solution caused an unblocking effect, so that the IGABA amplitude increased 7-fold. However, the addition of 0.5 µM Zolp to the GBZ solution did not cause an unblocking effect. So, Allo appeared to have a stronger unblocking potential than Zolp, and Bic binding site showed a higher sensitivity to the action of unblocking PAMs than GBZ binding site. The results indicate for the first time the existence of an allosteric relationship between the sites binding PAMs and the competitive antagonists of GABAAR.


Sujet(s)
Chlorures , Récepteurs GABA-A , Rats , Animaux , Récepteurs GABA-A/composition chimique , Chlorures/métabolisme , Ligands , Acide gamma-amino-butyrique/métabolisme , Acide gamma-amino-butyrique/pharmacologie , Prégnanolone/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie
7.
J Biol Chem ; 298(9): 102278, 2022 09.
Article de Anglais | MEDLINE | ID: mdl-35863435

RÉSUMÉ

Immediate early genes (IEGs) are transcribed in response to neuronal activity from sensory stimulation during multiple adaptive processes in the brain. The transcriptional profile of IEGs is indicative of the duration of neuronal activity, but its sensitivity to the strength of depolarization remains unknown. Also unknown is whether activity history of graded potential changes influence future neuronal activity. In this work with dissociated rat cortical neurons, we found that mild depolarization-mediated by elevated extracellular potassium (K+)-induces a wide array of rapid IEGs and transiently depresses transcriptional and signaling responses to a successive stimulus. This latter effect was independent of de novo transcription, translation, and signaling via calcineurin or mitogen-activated protein kinase. Furthermore, as measured by multiple electrode arrays and calcium imaging, mild depolarization acutely subdues subsequent spontaneous and bicuculline-evoked activity via calcium- and N-methyl-d-aspartate receptor-dependent mechanisms. Collectively, this work suggests that a recent history of graded potential changes acutely depress neuronal intrinsic properties and subsequent responses. Such effects may have several potential downstream implications, including reducing signal-to-noise ratio during synaptic plasticity processes.


Sujet(s)
Potentiels d'action , Calcineurine , Gènes précoces , Neurones , Transcription génétique , Potentiels d'action/effets des médicaments et des substances chimiques , Potentiels d'action/physiologie , Animaux , Bicuculline/pharmacologie , Calcineurine/génétique , Calcineurine/métabolisme , Calcium/métabolisme , Antagonistes du récepteur GABA-A/pharmacologie , Gènes précoces/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolisme , Neurones/effets des médicaments et des substances chimiques , Neurones/physiologie , Potassium/métabolisme , Potassium/pharmacologie , Rats , Récepteurs du N-méthyl-D-aspartate/génétique , Récepteurs du N-méthyl-D-aspartate/métabolisme
8.
Eur J Pharmacol ; 925: 174992, 2022 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-35513017

RÉSUMÉ

Gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in adults, has a critical contribution to balanced excitatory-inhibitory networks in the brain. Alteration in depolarizing action of GABA during early life is connected to a wide variety of neurodevelopmental disorders. Additionally, the effects of postnatal GABA blockade on neuronal synaptic plasticity are not known and therefore, we set out to determine whether postnatal exposure to bicuculline, a competitive antagonist of GABAA receptors, affects electrophysiologic changes in hippocampal CA1 neurons later on. To this end, male and female Wistar rats received vehicle or bicuculline (300 µg/kg) on postnatal days (PNDs) 7, 9 and 11, and then underwent different behavioral and electrophysiological examinations in adulthood. Postnatal exposure to bicuculline did not affect basic synaptic transmission but led to a pronounced decrease in paired-pulse facilitation (PPF) in CA1 pyramidal neurons. Bicuculline treatment also attenuated the long-term potentiation (LTP) and long-term depression (LTD) of CA1 neurons accompanied by decreased theta-burst responses in male and female adult rats. These electrophysiology findings together with the reduced brain-derived neurotrophic factor (BDNF) levels in the hippocampus and prefrontal cortex reliably explain the disturbance in spatial reference and working memories of bicuculline-treated animals. This study suggests that postnatal GABAA blockade deteriorates short- and long-term synaptic plasticity of hippocampal CA1 neurons and related encoding of spatial memory in adulthood.


Sujet(s)
Bicuculline , Antagonistes du récepteur GABA-A , Potentialisation à long terme , Plasticité neuronale , Animaux , Bicuculline/pharmacologie , Cognition , Femelle , Antagonistes du récepteur GABA-A/pharmacologie , Hippocampe , Mâle , Rats , Rat Wistar , Récepteurs GABA-A/métabolisme , Transmission synaptique , Acide gamma-amino-butyrique
9.
Neuroscience ; 490: 120-130, 2022 05 10.
Article de Anglais | MEDLINE | ID: mdl-35276306

RÉSUMÉ

Antisecretory Factor (AF) is an endogenous peptide known for its powerful antisecretory and anti-inflammatory properties. We have previously shown that AF also acts as a neuromodulator of GABAergic synaptic transmission in rat hippocampus in a way that results in disinhibition of CA1 pyramidal neurons. Disinhibition is expected to facilitate the induction of long-term potentiation (LTP), and LTP is known to play a crucial role in learning and memory acquisition. In the present study we investigated the effect of AF on LTP in CA3-CA1 synapses in rat hippocampus. In addition, endogenous AF plasma activity was upregulated by feeding the rats with specially processed cereals (SPC) and spatial learning and memory was studied in the Morris Water Maze (MWM). We found that LTP was significantly enhanced in the presence of AF, both when added exogenously in vitro as well as when upregulated endogenously by SPC-feeding. In the presence of the GABAA-receptor antagonist picrotoxin (PTX) there was however no significant enhancement of LTP. Moreover, rats fed with SPC demonstrated enhanced spatial learning and short-term memory, compared with control animals. These results show that the disinhibition of GABAergic transmission in the hippocampus by the endogenous peptide AF enhances LTP as well as spatial learning and memory.


Sujet(s)
Potentialisation à long terme , Neuropeptides , Animaux , Antagonistes du récepteur GABA-A/pharmacologie , Hippocampe , Potentialisation à long terme/physiologie , Apprentissage du labyrinthe , Neuropeptides/pharmacologie , Rats , Rat Wistar , Régulation positive
10.
Nature ; 602(7897): 529-533, 2022 02.
Article de Anglais | MEDLINE | ID: mdl-35140402

RÉSUMÉ

Type A GABA (γ-aminobutyric acid) receptors represent a diverse population in the mammalian brain, forming pentamers from combinations of α-, ß-, γ-, δ-, ε-, ρ-, θ- and π-subunits1. αß, α4ßδ, α6ßδ and α5ßγ receptors favour extrasynaptic localization, and mediate an essential persistent (tonic) inhibitory conductance in many regions of the mammalian brain1,2. Mutations of these receptors in humans are linked to epilepsy and insomnia3,4. Altered extrasynaptic receptor function is implicated in insomnia, stroke and Angelman and Fragile X syndromes1,5, and drugs targeting these receptors are used to treat postpartum depression6. Tonic GABAergic responses are moderated to avoid excessive suppression of neuronal communication, and can exhibit high sensitivity to Zn2+ blockade, in contrast to synapse-preferring α1ßγ, α2ßγ and α3ßγ receptor responses5,7-12. Here, to resolve these distinctive features, we determined structures of the predominantly extrasynaptic αß GABAA receptor class. An inhibited state bound by both the lethal paralysing agent α-cobratoxin13 and Zn2+ was used in comparisons with GABA-Zn2+ and GABA-bound structures. Zn2+ nullifies the GABA response by non-competitively plugging the extracellular end of the pore to block chloride conductance. In the absence of Zn2+, the GABA signalling response initially follows the canonical route until it reaches the pore. In contrast to synaptic GABAA receptors, expansion of the midway pore activation gate is limited and it remains closed, reflecting the intrinsic low efficacy that characterizes the extrasynaptic receptor. Overall, this study explains distinct traits adopted by αß receptors that adapt them to a role in tonic signalling.


Sujet(s)
Agonistes du récepteur GABA-A , Antagonistes du récepteur GABA-A , Récepteurs GABA-A , Animaux , Neurotoxines de venin de cobra , Agonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Humains , Mammifères/métabolisme , Inhibition nerveuse/physiologie , Neurones/métabolisme , Récepteurs GABA-A/métabolisme , Synapses/métabolisme , Zinc , Acide gamma-amino-butyrique/métabolisme
11.
Cell Rep ; 38(1): 110153, 2022 01 04.
Article de Anglais | MEDLINE | ID: mdl-34986356

RÉSUMÉ

Synaptic plasticity is long-lasting changes in synaptic currents and structure. When neurons are exposed to signals that induce aberrant neuronal excitation, they increase the threshold for the induction of long-term potentiation (LTP), known as metaplasticity. However, the metaplastic regulation of structural LTP (sLTP) remains unclear. We investigate glutamate uncaging/photoactivatable (pa)CaMKII-dependent sLTP induction in hippocampal CA1 neurons after chronic neuronal excitation by GABAA receptor antagonists. We find that the neuronal excitation decreases the glutamate uncaging-evoked Ca2+ influx mediated by GluN2B-containing NMDA receptors and suppresses sLTP induction. In addition, single-spine optogenetic stimulation using paCaMKII indicates the suppression of CaMKII signaling. While the inhibition of Ca2+ influx is protein synthesis independent, the paCaMKII-induced sLTP suppression depends on it. Our findings demonstrate that chronic neuronal excitation suppresses sLTP in two independent ways (i.e., dual inhibition of Ca2+ influx and CaMKII signaling). This dual inhibition mechanism may contribute to robust neuronal protection in excitable environments.


Sujet(s)
Calcium-Calmodulin-Dependent Protein Kinase Type 2/métabolisme , Potentialisation à long terme/physiologie , Plasticité neuronale/physiologie , Neurones/métabolisme , Récepteurs du N-méthyl-D-aspartate/physiologie , Animaux , Région CA1 de l'hippocampe/métabolisme , Calcium/métabolisme , Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonistes et inhibiteurs , Lignée cellulaire , Épines dendritiques/métabolisme , Antagonistes du récepteur GABA-A/pharmacologie , Acide glutamique/métabolisme , Cellules HEK293 , Humains , Souris , Souris de lignée C57BL , Récepteurs GABA-A/métabolisme , Transduction du signal/physiologie
12.
J Neurophysiol ; 127(1): 267-278, 2022 01 01.
Article de Anglais | MEDLINE | ID: mdl-34879205

RÉSUMÉ

Brainstem respiratory neuronal network significantly contributes to cough motor pattern generation. Neuronal populations in the pre-Bötzinger complex (PreBötC) represent a substantial component for respiratory rhythmogenesis. We studied the role of PreBötC neuronal excitation and inhibition on mechanically induced tracheobronchial cough in 15 spontaneously breathing, pentobarbital anesthetized adult cats (35 mg/kg, iv initially). Neuronal excitation by unilateral microinjection of glutamate analog d,l-homocysteic acid resulted in mild reduction of cough abdominal electromyogram (EMG) amplitudes and very limited temporal changes of cough compared with effects on breathing (very high respiratory rate, high amplitude inspiratory bursts with a short inspiratory phase, and tonic inspiratory motor component). Mean arterial blood pressure temporarily decreased. Blocking glutamate-related neuronal excitation by bilateral microinjections of nonspecific glutamate receptor antagonist kynurenic acid reduced cough inspiratory and expiratory EMG amplitude and shortened most cough temporal characteristics similarly to breathing temporal characteristics. Respiratory rate decreased and blood pressure temporarily increased. Limiting active neuronal inhibition by unilateral and bilateral microinjections of GABAA receptor antagonist gabazine resulted in lower cough number, reduced expiratory cough efforts, and prolongation of cough temporal features and breathing phases (with lower respiratory rate). The PreBötC is important for cough motor pattern generation. Excitatory glutamatergic neurotransmission in the PreBötC is involved in control of cough intensity and patterning. GABAA receptor-related inhibition in the PreBötC strongly affects breathing and coughing phase durations in the same manner, as well as cough expiratory efforts. In conclusion, differences in effects on cough and breathing are consistent with separate control of these behaviors.NEW & NOTEWORTHY This study is the first to explore the role of the inspiratory rhythm and pattern generator, the pre-Bötzinger complex (PreBötC), in cough motor pattern formation. In the PreBötC, excitatory glutamatergic neurotransmission affects cough intensity and patterning but not rhythm, and GABAA receptor-related inhibition affects coughing and breathing phase durations similarly to each other. Our data show that the PreBötC is important for cough motor pattern generation, but cough rhythmogenesis appears to be controlled elsewhere.


Sujet(s)
Générateurs centraux de rythme , Toux , Antagonistes des acides aminés excitateurs/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Acide glutamique/pharmacologie , Inspiration , Moelle allongée , Réflexe , Fréquence respiratoire , Muscles abdominaux/effets des médicaments et des substances chimiques , Muscles abdominaux/physiopathologie , Animaux , Comportement animal/effets des médicaments et des substances chimiques , Comportement animal/physiologie , Chats , Générateurs centraux de rythme/effets des médicaments et des substances chimiques , Générateurs centraux de rythme/métabolisme , Générateurs centraux de rythme/physiopathologie , Toux/traitement médicamenteux , Toux/métabolisme , Toux/physiopathologie , Électromyographie , Antagonistes des acides aminés excitateurs/administration et posologie , Femelle , Antagonistes du récepteur GABA-A/administration et posologie , Acide glutamique/administration et posologie , Acide glutamique/analyse , Homocystéine/analogues et dérivés , Homocystéine/pharmacologie , Inspiration/effets des médicaments et des substances chimiques , Inspiration/physiologie , Acide kynurénique/pharmacologie , Mâle , Moelle allongée/effets des médicaments et des substances chimiques , Moelle allongée/métabolisme , Moelle allongée/physiopathologie , Pyridazines/pharmacologie , Réflexe/effets des médicaments et des substances chimiques , Réflexe/physiologie , Fréquence respiratoire/effets des médicaments et des substances chimiques , Fréquence respiratoire/physiologie
13.
Neurosci Lett ; 771: 136396, 2022 02 06.
Article de Anglais | MEDLINE | ID: mdl-34919990

RÉSUMÉ

Cerebellar Purkinje cells (PCs) play critical roles in motor coordination and motor learning through their simple spike (SS) activity. Previous studies have shown that chronic ethanol exposure (CEE) in adolescents impairs learning, attention, and behavior, at least in part by impairing the activity of cerebellar PCs. In this study, we investigated the effect of CEE on the SS activity in urethane-anesthetized adolescent mice by in vivo electrophysiological recordings and pharmacological methods. Our results showed that the cerebellar PCs in CEE adolescent mice expressed a significant decrease in the frequency and an increase in the coefficient of variation (CV) of SS than control group. Blockade of ɤ-aminobutyric acid A (GABAA) receptor did not change the frequency and CV of SS firing in control group but produced a significant increase in the frequency and a decrease in the CV of SS firing in CEE mice. The CEE-induced decrease in SS firing rate and increase in CV were abolished by application of an N-methyl-D-aspartate (NMDA) receptor blocker, D-APV, but not by anα-amino-3-hydroxy-5-methyl -4-isoxazolepropionic acid (AMPA) receptor antagonist, NBQX. Notably, the spontaneous spike rate of molecular layer interneurons (MLIs) in CEE mice was significantly higher than control group, which was also abolished by application of D-APV. These results indicate that adolescent CEE enhances the spontaneous spike firing rate of MLIs through activation of NMDA receptor, resulting in a depression in the SS activity of cerebellar PCs in vivo in mice.


Sujet(s)
Potentiels d'action , Dépresseurs du système nerveux central/pharmacologie , Éthanol/pharmacologie , Cellules de Purkinje/effets des médicaments et des substances chimiques , Animaux , Encéphale/effets des médicaments et des substances chimiques , Encéphale/croissance et développement , Dépresseurs du système nerveux central/toxicité , Éthanol/toxicité , Femelle , Antagonistes du récepteur GABA-A/pharmacologie , Mâle , Souris , Souris de lignée ICR , Neurogenèse , Cellules de Purkinje/métabolisme , Cellules de Purkinje/physiologie , Récepteurs du N-méthyl-D-aspartate/antagonistes et inhibiteurs
14.
Neurosci Lett ; 766: 136344, 2022 01 01.
Article de Anglais | MEDLINE | ID: mdl-34785309

RÉSUMÉ

The present study aimed to examine the synergistic effects of exercise and pharmacological inhibition of the α5 subunit-containing gamma-aminobutyric acid (GABA)A receptors (α5GABAAR) on motor function recovery after intracerebral hemorrhage (ICH). Wistar rats were divided into five groups (n = 8 per group): SHAM, ICH, ICH + exercise (ICH + EX), ICH + L-655,708 (ICH + L6), and ICH + L-655,708 and exercise (ICH + L6EX) groups. ICH was induced by microinjection of a collagenase solution. The ICH + EX and ICH + L6EX groups exercised on a treadmill (12 m/min for 30 min/day). L-655,708 (0.5 mg/kg), a negative allosteric modulator of α5GABAAR, was administered intraperitoneally to the ICH + L6 and ICH + L6EX groups. Each intervention was initiated 1 week after the ICH surgery and was performed for 3 weeks, followed by tissue collection, including the motor cortex and spinal cord. At 4 weeks after ICH, significant motor recovery was found in the ICH + L6EX group compared to the ICH group. L-655,708 administration increased brain-derived neurotrophic factor (BDNF) expression in the cortex. Regarding neuroplastic changes in the spinal cord, rats in the ICH + L6EX group showed a significant increase in several neuroplastic markers: 1) BDNF, 2) growth-associated protein 43 as an axonal sprouting marker, 3) synaptophysin as a synaptic marker, and 4) Nogo-A as an axonal growth inhibitor. This study is the first to demonstrate that combined treatment with exercise and α5GABAAR inhibitor effectively promoted motor function recovery after ICH. Regarding the underlying mechanism of post-ICH recovery with the combined treatment, the present study highlights the importance of both growth and inhibitory modification of axonal sprouting in the spinal cord.


Sujet(s)
Hémorragie cérébrale , Antagonistes du récepteur GABA-A/pharmacologie , Imidazoles/pharmacologie , Conditionnement physique d'animal/méthodes , Récupération fonctionnelle/physiologie , Animaux , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Facteur neurotrophique dérivé du cerveau/métabolisme , Mâle , Activité motrice/effets des médicaments et des substances chimiques , Activité motrice/physiologie , Plasticité neuronale/effets des médicaments et des substances chimiques , Plasticité neuronale/physiologie , Rats , Rat Wistar , Récepteurs GABA-A , Récupération fonctionnelle/effets des médicaments et des substances chimiques , Moelle spinale/effets des médicaments et des substances chimiques
15.
J Neuroendocrinol ; 34(2): e13013, 2022 02.
Article de Anglais | MEDLINE | ID: mdl-34337790

RÉSUMÉ

GABA is the main inhibitory neurotransmitter in the brain and GABAergic transmission has been shown to be of importance for regulation of mood, memory and food intake. The progesterone metabolite allopregnanolone (Allo) is a positive GABAA receptor modulating steroid with potent effects. In humans, disorders such as premenstrual dysphoric disorder (PMDD), hepatic encephalopathy and polycystic ovarian syndrome are associated with elevated Allo levels and increased negative mood, disturbed memory and increased food intake in some individuals. This is surprising because Allo shares many properties with benzodiazepines and is mainly considered to be anxiolytic and anti-depressant. However, it is well established that, in certain individuals, GABAA receptor activating compounds could have paradoxical effects and thus be anxiogenic in low physiological plasma concentrations but anxiolytic at high levels. We have demonstrated that isoallopregnanolone (Isoallo), the 3ß-OH sibling of Allo, functions as a GABAA receptor modulating steroid antagonist (GAMSA) but without any effects of its own on GABAA receptors. The antagonistic effect is noted in most GABAA subtypes investigated in vitro to date. In vivo, Isoallo can inhibit Allo-induced anaesthesia in rats, as well as sedation or saccadic eye velocity in humans. Isoallo treatment has been studied in women with PMDD. In a first phase II study, Isoallo (Sepranolone; Asarina Pharma) injections significantly ameliorated negative mood in women with PMDD compared with placebo. Several GAMSAs for oral administration have also been developed. The GAMSA, UC1011, can inhibit Allo induced memory disturbances in rats and an oral GAMSA, GR3027, has been shown to restore learning and motor coordination in rats with hepatic encephalopathy. In humans, vigilance, cognition and pathological electroencephalogram were improved in patients with hepatic encephalopathy on treatment with GR3027. In conclusion GAMSAs are a new possible treatment for disorders and symptoms caused by hyperactivity in the GABAA system.


Sujet(s)
Anxiolytiques , Encéphalopathie hépatique , Trouble dysphorique prémenstruel , Animaux , Anxiolytiques/usage thérapeutique , Essais cliniques de phase II comme sujet , Femelle , Antagonistes du récepteur GABA-A/pharmacologie , Humains , Prégnanolone/métabolisme , Trouble dysphorique prémenstruel/métabolisme , Rats , Récepteurs GABA-A/métabolisme , Acide gamma-amino-butyrique
16.
Exp Neurol ; 347: 113881, 2022 01.
Article de Anglais | MEDLINE | ID: mdl-34597681

RÉSUMÉ

Hypo-excitability was reported in the peri-infarct tissue following stroke, an effect counteracted by a blockage of α5-GABAA receptors in adult rodents. Our present study aims to evaluate the effect of a selective α5-GABAA receptor antagonist, S 44819, in stroke in juvenile animals. We have set up and characterized an original model of transient ischemic stroke in 28 day-old Sprague-Dawley rats (45-min occlusion of the middle cerebral artery by intraluminal suture). In this model, S 44819 (1, 3 and 10 mg/kg, b.i.d) was orally administered from day 3 to day 16 after stroke onset. Sensorimotor recovery was assessed on day 1, day 9 and day 16 after stroke onset. Results show that rats treated with S 44819 at the doses of 3 and 10 mg/kg displayed a significant improvement of the neurological deficits (neuroscore) on day 9 and day 16, when compared with animals treated with vehicle. Grip-test data analysis reveals that rats treated with S 44819 at the dose of 3 mg/kg displayed a better recovery on day 9 and day 16. These results are in agreement with those previously observed in adult rats, demonstrating that targeting α5-GABAA receptors improves neurological recovery after stroke in juvenile rats.


Sujet(s)
Benzodiazépines/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Oxazoles/pharmacologie , Récupération fonctionnelle/effets des médicaments et des substances chimiques , Accident vasculaire cérébral/physiopathologie , Animaux , Mâle , Rats , Rat Sprague-Dawley
17.
Mol Brain ; 14(1): 139, 2021 09 10.
Article de Anglais | MEDLINE | ID: mdl-34507588

RÉSUMÉ

Chronic pain easily leads to concomitant mood disorders, and the excitability of anterior cingulate cortex (ACC) pyramidal neurons (PNs) is involved in chronic pain-related anxiety. However, the mechanism by which PNs regulate pain-related anxiety is still unknown. The GABAergic system plays an important role in modulating neuronal activity. In this paper, we aimed to study how the GABAergic system participates in regulating the excitability of ACC PNs, consequently affecting chronic inflammatory pain-related anxiety. A rat model of CFA-induced chronic inflammatory pain displayed anxiety-like behaviors, increased the excitability of ACC PNs, and reduced inhibitory presynaptic transmission; however, the number of GAD65/67 was not altered. Interestingly, intra-ACC injection of the GABAAR agonist muscimol relieved anxiety-like behaviors but had no effect on chronic inflammatory pain. Intra-ACC injection of the GABAAR antagonist picrotoxin induced anxiety-like behaviors but had no effect on pain in normal rats. Notably, chemogenetic activation of GABAergic neurons in the ACC alleviated chronic inflammatory pain and pain-induced anxiety-like behaviors, enhanced inhibitory presynaptic transmission, and reduced the excitability of ACC PNs. Chemogenetic inhibition of GABAergic neurons in the ACC led to pain-induced anxiety-like behaviors, reduced inhibitory presynaptic transmission, and enhanced the excitability of ACC PNs but had no effect on pain in normal rats. We demonstrate that the GABAergic system mediates a reduction in inhibitory presynaptic transmission in the ACC, which leads to enhanced excitability of pyramidal neurons in the ACC and is associated with chronic inflammatory pain-related anxiety.


Sujet(s)
Anxiété/physiopathologie , Douleur chronique/physiopathologie , Neurones GABAergiques/physiologie , Gyrus du cingulum/physiopathologie , Inflammation/psychologie , Cellules pyramidales/physiologie , Animaux , Anxiolytiques/administration et posologie , Anxiolytiques/pharmacologie , Anxiolytiques/usage thérapeutique , Anxiété/traitement médicamenteux , Anxiété/étiologie , Sensibilisation du système nerveux central/effets des médicaments et des substances chimiques , Douleur chronique/psychologie , Clozapine/usage thérapeutique , Adjuvant Freund/toxicité , Agonistes du récepteur GABA-A/administration et posologie , Agonistes du récepteur GABA-A/pharmacologie , Agonistes du récepteur GABA-A/usage thérapeutique , Antagonistes du récepteur GABA-A/administration et posologie , Antagonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/toxicité , Neurones GABAergiques/enzymologie , Vecteurs génétiques/pharmacologie , Inflammation/induit chimiquement , Inflammation/physiopathologie , Injections , Interneurones/effets des médicaments et des substances chimiques , Mâle , Muscimol/administration et posologie , Muscimol/pharmacologie , Muscimol/usage thérapeutique , Test en champ ouvert , Seuil nociceptif/effets des médicaments et des substances chimiques , Techniques de patch-clamp , Picrotoxine/toxicité , Terminaisons présynaptiques/effets des médicaments et des substances chimiques , Terminaisons présynaptiques/physiologie , Cellules pyramidales/enzymologie , Rats , Rat Sprague-Dawley
18.
Mol Brain ; 14(1): 130, 2021 08 24.
Article de Anglais | MEDLINE | ID: mdl-34429141

RÉSUMÉ

Somatostatin-expressing interneurons (SOM-INs) are a major subpopulation of GABAergic cells in CA1 hippocampus that receive excitation from pyramidal cells (PCs), and, in turn, provide feedback inhibition onto PC dendrites. Excitatory synapses onto SOM-INs show a Hebbian long-term potentiation (LTP) mediated by type 1a metabotropic glutamate receptors (mGluR1a) that is implicated in hippocampus-dependent learning. The neuropeptide somatostatin (SST) is also critical for hippocampal long-term synaptic plasticity, as well as learning and memory. SST effects on hippocampal PCs are well documented, but its actions on inhibitory interneurons remain largely undetermined. In the present work, we investigate the involvement of SST in long-term potentiation of CA1 SOM-IN excitatory synapses using pharmacological approaches targeting the somatostatinergic system and whole cell recordings in slices from transgenic mice expressing eYFP in SOM-INs. We report that application of exogenous SST14 induces long-term potentiation of excitatory postsynaptic potentials in SOM-INs via somatostatin type 1-5 receptors (SST1-5Rs) but does not affect synapses of PC or parvalbumin-expressing interneurons. Hebbian LTP in SOM-INs was prevented by inhibition of SSTRs and by depletion of SST by cysteamine treatment, suggesting a critical role of endogenous SST in LTP. LTP of SOM-IN excitatory synapses induced by SST14 was independent of NMDAR and mGluR1a, activity-dependent, and prevented by blocking GABAA receptor function. Our results indicate that endogenous SST may contribute to Hebbian LTP at excitatory synapses of SOM-INs by controlling GABAA inhibition, uncovering a novel role for SST in regulating long-term synaptic plasticity in somatostatinergic cells that may be important for hippocampus-dependent memory processes.


Sujet(s)
Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Neurones GABAergiques/effets des médicaments et des substances chimiques , Interneurones/effets des médicaments et des substances chimiques , Potentialisation à long terme/effets des médicaments et des substances chimiques , Somatostatine/physiologie , Synapses/effets des médicaments et des substances chimiques , Animaux , Protéines bactériennes , Mercaptamine/pharmacologie , Femelle , Antagonistes du récepteur GABA-A/pharmacologie , Neurones GABAergiques/métabolisme , Techniques de knock-in de gènes , Gènes rapporteurs , Humains , Interneurones/métabolisme , Protéines luminescentes , Mâle , Mémoire/physiologie , Souris , Souris transgéniques , Peptides cycliques/pharmacologie , Récepteurs métabotropes au glutamate/physiologie , Récepteurs du N-méthyl-D-aspartate/physiologie , Récepteur somatostatine/effets des médicaments et des substances chimiques , Récepteur somatostatine/physiologie , Somatostatine/pharmacologie , Synapses/physiologie
19.
J Neurosci ; 41(39): 8103-8110, 2021 09 29.
Article de Anglais | MEDLINE | ID: mdl-34385360

RÉSUMÉ

Entorhinal cortex neurons make monosynaptic connections onto distal apical dendrites of CA1 and CA2 pyramidal neurons through the perforant path (PP) projection. Previous studies show that differences in dendritic properties and synaptic input density enable the PP inputs to produce a much stronger excitation of CA2 compared with CA1 pyramidal neurons. Here, using mice of both sexes, we report that the difference in PP efficacy varies substantially as a function of presynaptic firing rate. Although a single PP stimulus evokes a 5- to 6-fold greater EPSP in CA2 compared with CA1, a brief high-frequency train of PP stimuli evokes a strongly facilitating postsynaptic response in CA1, with relatively little change in CA2. Furthermore, we demonstrate that blockade of NMDARs significantly reduces strong temporal summation in CA1 but has little impact on that in CA2. As a result of the differences in the frequency- and NMDAR-dependent temporal summation, naturalistic patterns of presynaptic activity evoke CA1 and CA2 responses with distinct dynamics, differentially tuning CA1 and CA2 responses to bursts of presynaptic firing versus single presynaptic spikes, respectively.SIGNIFICANCE STATEMENT Recent studies have demonstrated that abundant entorhinal cortical innervation and efficient dendritic propagation enable hippocampal CA2 pyramidal neurons to produce robust excitation evoked by single cortical stimuli, compared with CA1. Here we uncovered, unexpectedly, that the difference in efficacy of cortical excitation varies substantially as a function of presynaptic firing rate. A burst of stimuli evokes a strongly facilitating response in CA1, but not in CA2. As a result, the postsynaptic response of CA1 and CA2 to presynaptic naturalistic firing displays contrasting temporal dynamics, which depends on the activation of NMDARs. Thus, whereas CA2 responds to single stimuli, CA1 is selectively recruited by bursts of cortical input.


Sujet(s)
Région CA1 de l'hippocampe/physiologie , Région CA2 de l'hippocampe/physiologie , Cortex cérébral/physiologie , Potentiels post-synaptiques excitateurs/physiologie , Cellules pyramidales/physiologie , Synapses/physiologie , Animaux , Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Région CA2 de l'hippocampe/effets des médicaments et des substances chimiques , Cortex cérébral/effets des médicaments et des substances chimiques , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Femelle , Antagonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-B/pharmacologie , Mâle , Souris , Voies nerveuses/effets des médicaments et des substances chimiques , Voies nerveuses/physiologie , Techniques de patch-clamp , Cellules pyramidales/effets des médicaments et des substances chimiques , Synapses/effets des médicaments et des substances chimiques
20.
Biomolecules ; 11(7)2021 07 15.
Article de Anglais | MEDLINE | ID: mdl-34356653

RÉSUMÉ

Rosmarinic acid, a major component of rosemary, is a polyphenolic compound with potential neuroprotective effects. Asreducing the synaptic release of glutamate is crucial to achieving neuroprotectant's pharmacotherapeutic effects, the effect of rosmarinic acid on glutamate release was investigated in rat cerebrocortical nerve terminals (synaptosomes). Rosmarinic acid depressed the 4-aminopyridine (4-AP)-induced glutamate release in a concentration-dependent manner. The removal of extracellular calcium and the blockade of vesicular transporters prevented the inhibition of glutamate release by rosmarinic acid. Rosmarinic acid reduced 4-AP-induced intrasynaptosomal Ca2+ elevation. The inhibition of N-, P/Q-type Ca2+ channels and the calcium/calmodulin-dependent kinase II (CaMKII) prevented rosmarinic acid from having effects on glutamate release. Rosmarinic acid also reduced the 4-AP-induced activation of CaMKII and the subsequent phosphorylation of synapsin I, the main presynaptic target of CaMKII. In addition, immunocytochemistry confirmed the presence of GABAA receptors. GABAA receptor agonist and antagonist blocked the inhibitory effect of rosmarinic acid on 4-AP-evoked glutamate release. Docking data also revealed that rosmarinic acid formed a hydrogen bond with the amino acid residues of GABAA receptor. These results suggested that rosmarinic acid activates GABAA receptors in cerebrocortical synaptosomes to decrease Ca2+ influx and CaMKII/synapsin I pathway to inhibit the evoked glutamate release.


Sujet(s)
Cinnamates/pharmacologie , Depsides/pharmacologie , Acide glutamique/métabolisme , Synaptosomes/effets des médicaments et des substances chimiques , 4-Amino-pyridine/pharmacologie , Animaux , Calcium/métabolisme , Inhibiteurs des canaux calciques/pharmacologie , Cortex cérébral/effets des médicaments et des substances chimiques , Cortex cérébral/métabolisme , Cinnamates/composition chimique , Depsides/composition chimique , Agonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/pharmacologie , Mâle , Potentiels de membrane/effets des médicaments et des substances chimiques , Simulation de docking moléculaire , Neuroprotecteurs/pharmacologie , Phosphorylation/effets des médicaments et des substances chimiques , Inhibiteurs de protéines kinases/pharmacologie , Rat Sprague-Dawley , Récepteurs GABA-A/composition chimique , Récepteurs GABA-A/métabolisme , Synaptosomes/métabolisme ,
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE